我国医药制造业技术创新效率及其影响因素研究

发布时间：2018-01-12 16:09

本文关键词：我国医药制造业技术创新效率及其影响因素研究　出处：《广东药科大学》2017年硕士论文　论文类型：学位论文

【摘要】：医药制造业是一个以技术创新为发展原动力的行业,具备一定的创新能力才能在世界市场上占得先机。在当今世界激烈角逐的市场环境下,技术创新能力的竞争已不再是单纯的人力、物力资源投入多少的较量。如何在现有投入下实现最大产出或保持产出不变的情况下投入最小,即效率问题,才是帮助制药企业实现利润最大化、提高医药制造业技术创新能力和水平的关键。因此,本文以创新效率的测算为基础,从国内目前的政策环境出发,探索能够优化创新投入结构的有效途径,有助于针对性的调整资源配置,使得效率改进工作更加富有针对性。本文在回顾国内外相关研究的基础上,提出以研发人员FTE(Full Time Equivalent,折合全时当量,缩写FTE)、研发经费内部支出、根据技术更新的常规路径所确定的指标技术改造、引进以及消化吸收所花费的支出为医药制造业技术创新投入,新产品销售收入以及专利申请数为技术创新产出的3投入2产出指标体系。利用Deap2.1软件对我国24个省市及化学药品、中成药品和生物药品,这三大行业的医药制造业的创新效率进行评价。根据效率测度结果,以省域为研究对象,运用Eviews6.0软件使用面板数据模型对作用于创新效率的各种原因进行分析。基于对效率水平及作用于它的各类因素测算,本文得出结论:研发资金投入、政府支持力度、新产品需求度所产生的作用力是正向的;研发人员投入、企业规模、外商投资对创新效率的影响负向的,这些因素的增加或扩大会阻碍创新效率的提高。据此,本文在分析制药水平领先的美国、日本及与我国医药产业发展路径相似的印度的创新发展模式的基础上,提出如下几点建议:(1)加强研发资金投入,仿创结合积累资本;(2)充分发挥研发人员效用,减少人力资源闲置;(3)加大政府资金投入,加强政府财政政策支持,同时强化专利保护政策;(4)建立以市场为导向的新药研发决策程序;(5)统筹对外开放和市场保护。
[Abstract]:Pharmaceutical manufacturing industry is a technology innovation as the driving force of the industry, with a certain degree of innovation in the world market in order to occupy the first opportunity, in today's fierce competition in the world market environment. The competition of technological innovation ability is no longer a simple contest of manpower and material resources. How to achieve the maximum output under the existing input or to keep the output unchanged is the problem of efficiency. It is the key to help pharmaceutical enterprises to maximize profits and improve the technological innovation ability and level of pharmaceutical manufacturing industry. Therefore, based on the measurement of innovation efficiency, this paper starts from the current domestic policy environment. To explore an effective way to optimize the structure of innovation input, help to adjust the allocation of resources, and make the efficiency improvement more targeted. This paper reviews the relevant research at home and abroad. It is proposed that FTE(Full Time equivalent, abbreviated as FTE(Full Time equivalent, be used as the internal expenditure of R & D funds. According to the technical transformation of the indicators determined by the conventional path of technology renewal, the expenditure incurred by the introduction and absorption of the technical innovation investment for the pharmaceutical manufacturing industry. The new product sales income and patent application number are three input-output index system of technological innovation output. Using Deap2.1 software, 24 provinces and cities and chemicals, traditional Chinese patent medicine and biological drugs are analyzed. The innovation efficiency of pharmaceutical manufacturing industry in these three industries is evaluated. According to the result of efficiency measurement, the province is the research object. Using the Eviews6.0 software panel data model to analyze the various reasons for the efficiency of innovation. Based on the level of efficiency and the various factors acting on it. The conclusion of this paper is as follows: the influence of R & D investment, government support and demand degree of new products is positive; The influence of R & D personnel investment, enterprise size and foreign investment on innovation efficiency is negative. The increase or expansion of these factors will hinder the improvement of innovation efficiency. On the basis of the innovative development model of Japan and India, which is similar to China's pharmaceutical industry development path, this paper puts forward the following suggestions: strengthening R & D investment, combining imitation with creation to accumulate capital; 2) give full play to the utility of R & D personnel and reduce the idle human resources; (3) increasing government investment, strengthening government financial policy support, and strengthening patent protection policy at the same time; Establishing a market-oriented decision-making process for new drug research and development; 5) to coordinate opening up to the outside world and market protection.
【学位授予单位】：广东药科大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72;F273.1

【参考文献】